AI-driven solutions and strategic alliances showcase Medtronic's promise to enhance the efficiency and effectiveness of endoscopy DUBLIN, April 10, 2024 /PRNewswire/ -- Medtronic plc (MDT) (NYSE: MDT) ...

Please provide your email address to receive an email when new articles are posted on . Mean number of adenomas per procedure was higher with GI Genius vs. standard colonoscopy (1.56 vs. 1.21), as was ...

Agreement expands partnership between Medtronic and Cosmo Pharmaceuticals, set to transform endoscopy with cutting-edge AI technology DUBLIN, Dec. 11, 2023 /PRNewswire/ -- Medtronic plc (MDT) (NYSE: ...

Don’t underestimate the importance of your colon: It’s an essential organ that eliminates waste and harbors trillions of bacteria — the good kind that shield your gut and generate substances to ...

Atlanta-based Northside Hospital has added Medtronic’s GI Genius, an “intelligent” endoscopy module to help physicians detect cancerous polyps. GI Genius is the first FDA-cleared, computer-aided polyp ...

Artificial intelligence is showing promise in gastroenterology, and physicians are taking notice. As the buzz about AI in the GI space grows, Benjamin Levy III, MD, a gastroenterologist at University ...

DUBLIN, April 10, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced the latest advancements in artificial intelligence (AI) for endoscopic care by ...

Dublin, Ireland--(Newsfile Corp. - April 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announces that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, ...